118 HR 5663 IH: ALS Better Care Act
U.S. House of Representatives
2023-09-21
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I
118th CONGRESS
1st Session
H. R. 5663
IN THE HOUSE OF REPRESENTATIVES
September 21, 2023
Ms. Schakowsky (for herself, Mr. Quigley, Mr. Fitzpatrick, Mr. Crow, Mr. Bacon, Mr. Jackson of Illinois, and Mr. Bishop of Georgia) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to provide coverage of ALS-related services under the Medicare program for individuals diagnosed with amyotrophic lateral sclerosis, and for other purposes.
1.

Short title
This Act may be cited as the “ALS Better Care Act”.
2.

Findings
Congress makes the following findings:
(1)
Amyotrophic lateral sclerosis (in this section, referred to as “ALS”) is a progressive and debilitating neurodegenerative disease.
(2)
Key services that include (but are not limited to) evidence of providing specialized physician or nurse practitioner support, occupational therapy support, speech pathology support, physical therapy, dietary support, respiratory support, registered nurse support, and coordination of the furnishing of durable medical equipment are crucial for managing the complex medical needs of ALS patients.
(3)
Studies have shown ALS clinics that provide these key services to ALS patients extend these patients’ lifespans and improve the quality of their lives.
(4)
These key services are furnished by a range of healthcare professionals.
(5)
Facilities providing care to ALS patients currently face inadequate Medicare reimbursement for the key services they offer to these patients.
(6)
Insufficient reimbursement creates significant challenges for facilities specializing in ALS care, resulting in extended wait times for patients in need of crucial services and hampering the ability of these facilities to innovate and improve the quality of care provided to ALS patients.
(7)
Improved reimbursement rates would encourage facilities to invest in research, innovation, and technology, leading to enhanced treatment options for ALS and improved patient outcomes.
(8)
Remote medical management options for individuals suffering from ALS must be a crucial part of access to care for such individuals, especially those living in rural areas or care deserts.
(9)
Telehealth is an essential management option referred to in paragraph (6) and can assist in delivering timely and comprehensive care, as ALS patients living in rural areas or care deserts often face challenges in accessing specialized ALS care and could otherwise be required to travel long travel distances—often with caregivers or family members.
(10)
Telehealth is especially important in maintaining access to care for ALS patients as the disease progresses and ALS patients have more limited mobility, which may make it challenging to attend in-person appointments regularly.
(11)
Low funding and difficulty in staffing for ALS clinical trials delay the development and availability of potential treatments and therapies for individuals living with the disease.
(12)
Inadequate funding for ALS clinical trials also impedes the ability to attract and retain qualified researchers, clinicians, and support staff, limiting the overall progress and success of these trials.
3.

Providing for coverage of ALS-related services under the medicare program for individuals diagnosed with amyotrophic lateral sclerosis
(a)

In general
Subtitle E of title XVIII of the Social Security Act (42 U.S.C. 1395 et seq.) is amended by inserting after section 1881A the following new section:
“1881B.

Medicare coverage of ALS-related services for individuals diagnosed with amyotrophic lateral sclerosis
(a)

In general
In the case of a covered ALS individual, the Secretary shall establish a supplemental facility-based payment system described in subsection (d) for ALS-related services provided to such an individual.
(b)

Covered ALS individual
For purposes of this section, the term covered ALS individual means an individual who is medically determined to have amyotrophic lateral sclerosis (as described in section 226(h)).
(c)

ALS-Related services
For purposes of this section, the term ALS-related services means items and services that are furnished to a covered ALS individual in an outpatient setting by a qualified provider (or by others under arrangements with them made by the qualified provider) for the care and treatment of such an individual with respect to the progression of amyotrophic lateral sclerosis.
(d)

Payment system
(1)

Authority
The Secretary shall establish a payment system under which a single payment determined in accordance with the succeeding paragraphs is made to a qualified provider for ALS-related services furnished to a covered ALS individual during a visit beginning on and after January 1, 2025, for the purpose of reimbursing the qualified provider (or clinic, if applicable) for furnishing ALS-related services.
(2)

Base payment amount
(A)

2025
For coverage year 2025, the Secretary shall establish a single payment amount for ALS-related services equal to $800 for such services furnished for each visit during such year.
(B)

2026
For coverage year 2026, the Secretary shall establish a single payment amount for ALS-related services furnished for each visit during such year that is the greater of—
(i)
the payment amount recommended by the Comptroller General in the report described in subparagraph (D)(i); or
(ii)
the amount specified in subparagraph (A).
(C)

Subsequent years
The Secretary shall do each of the following:
(i)

Annual increase
For each coverage year beginning with coverage year 2027, the Secretary shall annually increase the payment amount for each visit determined under this paragraph by an ALS services market basket percentage increase (as determined by the Secretary) for the purpose of reflecting the year-to-year changes in the prices of an appropriate mix of goods and services that are ALS-related services.
(ii)

Reestablishment of amount
For each coverage year beginning with coverage year 2028, and every three coverage years thereafter, the Secretary shall reestablish a single payment amount for ALS-related services furnished for each visit during such year that is the greater of—
(I)
the payment amount recommended by the Comptroller General in the report described in subclause (I) or (II) of subparagraph (D)(ii), as appropriate; or
(II)
the payment amount specified pursuant to clause (i); for the purpose of ensuring that the range of ALS-related services is modernized over time.
(D)

Report by the comptroller general
Not later than January 1, 2025, the Comptroller General shall, in consultation with qualified providers that are representative of the types of qualified providers eligible for payment under this subsection, submit to the Secretary of Health and Human Services a report that recommends a single payment amount for ALS-related services that takes into account the average amount of payment for each item or service included in ALS-related services that the Comptroller General estimates would have been payable—
(i)
under this title for such a service based on per patient utilization data from whichever single coverage year from 2021 through 2023 has the highest per patient utilization of ALS-related services, even if such service is not payable for a particular ALS individual because of the application of section 1862(a)(1)(A) with respect to an item or service provided to such individual;
(ii)
in the case an estimate is unable to be determined pursuant to subclause (I), by health insurance issuers and group health plans (as such terms are defined in section 2791 of the Public Health Service Act) and MA plans under part C for such a service, based on such data from whichever single coverage year from 2021 through 2023 has the highest per patient utilization of ALS-related services; and
(iii)
in the case an estimate is unable to be determined pursuant to subclause (II), based on the recommendation of the Specialty Society Relative Value Scale Update Committee of the American Medical Association or the estimate of the Comptroller General for such a service.
(E)

Subsequent reports
For the purpose of subparagraph (C)(ii)(I), the Comptroller General shall, not later than—
(i)
January 1, 2028, submit a report to the Secretary in accordance with clause (i), except by substituting “2021 through 2023” for “2024 through 2026”; and
(ii)
three years after the date specified in subclause (I), and every three years thereafter, submit a report to the Secretary in accordance with such clause (i), except by substituting the coverage years for the previous report with coverage years that are three years later.
(3)

Payment adjustments
The payment system under this subsection shall include a payment adjustment—
(A)
for a qualified provider that is participating in at least one clinical trial identified on the clinicaltrials.gov database (or any successor database) of the National Institutes of Health to account for the increased costs borne by such a qualified provider during such a clinical trial; and
(B)
for a medical service or technology which is furnished as a part of ALS-related services for which, as determined by the Secretary—
(i)
payment for the service or technology as part of ALS-related services under this section was not being made in the preceding coverage year; and
(ii)
the cost of the service or technology is not insignificant in relation to the payment amount (as determined under this subsection) payable for ALS-related services.
(4)

Mechanism for payments
For purposes of making payments for ALS-related services, the Secretary shall establish a mechanism under the payment system under this subsection which makes payment when a qualified provider submits a claim for reimbursement which includes, with respect to a covered ALS individual, an alphanumeric code issued under the International Classification of Diseases, 10th Revision, Clinical Modification (“ICD–10–CM”) and its subsequent revisions that is for the treatment of a diagnosis of amyotrophic lateral sclerosis.
(5)

No cost sharing
Payment under this subsection shall be made only on an assignment-related basis without any cost sharing.
(6)

Qualified provider defined
In this section, the term qualified provider means a provider of services which—
(A)
is capable of furnishing care to a covered ALS individual that includes (but is not limited to) evidence of providing specialized physician or nurse practitioner support, occupational therapy support, speech pathology support, physical therapy, dietary support, respiratory support, registered nurse support, and coordination of the furnishing of durable medical equipment; and
(B)
meets requirements as the Secretary prescribes by regulation to implement subparagraph (A), in consultation with—
(i)
covered ALS individuals and their representatives;
(ii)
physicians who provide ALS-related services and their representatives; and
(iii)
professional and non-profit organizations with expertise in amyotrophic lateral sclerosis.
(e)

Clarification
Payment under subsection (d) shall be in addition to, and shall not supplant, any payment that would be otherwise made to a provider of services, physician, practitioner, supplier, or laboratory under any other provision of this title for an item or service furnished to a covered ALS individual.
(f)

Implementation
(1)

In general
Except as provided under paragraph (2), the Secretary may implement the provisions of this section by program instruction or otherwise.
(2)

Rulemaking
The Secretary shall implement subsections (c) and (d)(6) through notice and comment rulemaking.
(g)

Funding
For purposes of carrying out this section, subject to subsection (e), payment under this section shall be made from the Federal Supplementary Medical Insurance Trust Fund under section 1841 or from the Federal Hospital Insurance Trust Fund under section 1817.”.
(b)

Conforming amendments
(1)
Section 1833(t) of the Social Security Act (42 U.S.C. 1395(t)) is amended by adding at the end the following new paragraph:
“(23)

Ensuring supplemental payments for ALS-related services
Any covered OPD service furnished to a covered ALS individual (as defined in section 1881B(b)) that is otherwise payable to a qualified provider (as defined in section 1881B(d)(6)) pursuant to paragraph (4) shall be payable under such paragraph notwithstanding any payment made under section 1881B(d).”.
(2)
Section 1861(w)(1) of the Social Security Act (42 U.S.C. 1395x(w)(1)) is amended by inserting “qualified provider (as defined in section 1881B(d)(6)(A)) with respect to ALS-related services (as defined in section 1881B(c)),” before “or hospice program”.
4.

Report on challenges with respect to the administration and staffing of amyotrophic lateral sclerosis clinical trials
Not later than 90 days after the date of the enactment of this Act, the Secretary of Health and Human Services, acting through the Director of the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, shall submit to Congress and publish on the internet website of the agency a report that identifies—
(1)
any challenges with respect to the administration and staffing of clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of amyotrophic lateral sclerosis;
(2)
actions that the Director of the National Institute of Neurological Disorders and Stroke to address such challenges; and
(3)
any legislative recommendations (including requests for appropriations) to further improve the administration of such clinical trials.
5.

Effective date
The amendments made by this Act shall take effect on the date of the enactment of this Act.